Is it safe to combine liraglutide (GLP‑1 receptor agonist) with an Atlantis medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Clarification Needed: "Atlantis" is Not a Recognized Medication

I cannot provide a recommendation about combining liraglutide with "Atlantis" because Atlantis is not a recognized medication name in standard pharmaceutical databases, FDA-approved drug lists, or medical literature.

Possible Scenarios

You may be referring to one of the following:

1. Misspelling or Brand Name Confusion

  • Could you mean Xultophy (insulin degludec/liraglutide combination)?
  • Could you mean Farxiga/Forxiga (dapagliflozin, an SGLT-2 inhibitor)?
  • Could you mean another diabetes or cardiovascular medication?

2. If You Mean SGLT-2 Inhibitors (like Farxiga, Jardiance, Invokana)

Liraglutide can be safely combined with SGLT-2 inhibitors 1. The 2025 BMJ guideline explicitly states: "Most medications for which recommendations are provided can be used in combination (except for GLP-1 receptor agonists and tirzepatide, which have similar mechanisms of action)" 1. Recent evidence supports additive cardiovascular and kidney benefits when combining SGLT-2 inhibitors with GLP-1 receptor agonists in moderate-to-high risk adults 1.

Key considerations when combining:

  • Monitor for cumulative gastrointestinal side effects if the patient is also on metformin 1
  • SGLT-2 inhibitors increase genital mycotic infection risk (10-15% in women) 2
  • Adjust insulin secretagogue or insulin doses to prevent hypoglycemia 3
  • Both drug classes work through complementary mechanisms 2

3. Medications That CANNOT Be Combined with Liraglutide

Do not combine liraglutide with:

  • Other GLP-1 receptor agonists (semaglutide, dulaglutide, exenatide) 1
  • Tirzepatide (GLP-1/GIP dual agonist) - similar mechanism of action 1
  • Other liraglutide-containing products 3

Please Clarify

Provide the generic or brand name of the medication you're asking about, and I can give you a definitive, evidence-based recommendation about safety, drug interactions, and clinical considerations for combining it with liraglutide.

References

Related Questions

Can linaclotide (Linzess) be taken together with a glucagon‑like peptide‑1 receptor agonist (GLP‑1 RA)?
Can a patient taking hydroxychloroquine safely be started on a GLP‑1 receptor agonist?
How do GLP‑3 and GLP‑1 therapies compare in terms of indications and efficacy?
Do one‑meal‑a‑day (OMAD) fasting or intermittent fasting affect glucagon‑like peptide‑1 (GLP‑1) and other appetite‑regulating hormones in the brain?
For a patient with severe obesity, hyperlipidemia, and prediabetes, which glucagon‑like peptide‑1 (GLP‑1) receptor agonist should I request for coverage under [INSURANCE_PLAN], and what ICD‑10‑CM diagnosis codes and HCPCS medication codes should be used to maximize approval?
How should hair loss be evaluated, including history, physical exam, and appropriate laboratory tests?
What is the appropriate dosing regimen for diltiazem?
What are the potential side effects of augmenting vilazodone with buspirone in a patient with generalized anxiety disorder who has a partial response to vilazodone?
Match each described scenario with the appropriate epidemiologic term: best methodology for an experimental study to establish cause‑effect relationships; confounding control at the analysis level; confounding control at the design level of a case‑control study; essential element of an ethical study; example of a predisposing factor (fair skin); example of effect modification; most appropriate measure for a disease‑outbreak investigation; example of an enabling factor (living conditions); contribution of a 25‑year‑old’s death from heart attack.
What is the appropriate evaluation and management of alopecia in a 20-year-old male?
How is liraglutide administered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.